A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
NCT04857372
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
137
Enrollment
INDUSTRY
Sponsor class
Conditions
Mesothelioma
Interventions
DRUG:
IAG933
Sponsor
Novartis Pharmaceuticals